CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Mylan Pharmaceuticals Inc recalls Carton label

Read the official FDA notice

Published
9 Sept 2026
Units affected
11,336 units
Agency
FDA
Country
United States

The hazard

Failed Dissolution Specifications

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Carton label: Mycophenolate Mofetil for injection, USP, 500 mg/vial, Sterile, 4 Single Dose Vials, Rx only, Manufactured for: Mylan Institutional LLC, Morgantown, WV 26505, Made in India, NDC 67457-386-81. Vial Label: Mycophenolate Mofetil for injection, USP, 500 mg/vial, Sterile, Single Dose Vial, Rx only, Manufactured for: Mylan Institutional LLC, Morgantown, WV 26505, Made in India, NDC 67457-386-00.

Brand / company
Mylan Pharmaceuticals Inc
Codes / lots
Lot: 3242616, Exp. April 2027; 8220216, Exp. Nov 2027
Distribution
U.S. Nationwide
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 9 Sept 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.